glp 1 and gip medication GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP1-GIP receptor co-agonists: a promising

You should not use GLP-1 injections if you: Have a known allergy to the medication Are pregnant Have severe gastrointestinal diseases such as gastroparesis Have a history of pancreatitis Have a personal or family history of MEN 2 or MTC Because of these risks, GLP-1 injections should only be prescribed and monitored by a licensed healthcare professional

Esta es una medicacin beneficiosa, pero hay que utilizarla con cuidado y con responsabilidad

FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L

Domande frequenti sui GLP-1 I GLP-1 sono farmaci dimagranti